Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Azithromycin Protects against Zika virus Infection by Upregulating virus-induced Type I and III Interferon Responses.

Li C, Zu S, Deng YQ, Li D, Parvatiyar K, Quanquin N, Shang J, Sun N, Su J, Liu Z, Wang M, Aliyari SR, Li XF, Wu A, Ma F, Shi Y, Nielsevn-Saines K, Jung JU, Qin FX, Qin CF, Cheng G.

Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.00394-19. doi: 10.1128/AAC.00394-19. [Epub ahead of print]

PMID:
31527024
2.

Zika virus shedding in the stool and infection through the anorectal mucosa in mice.

Li C, Deng YQ, Zu S, Quanquin N, Shang J, Tian M, Ji X, Zhang NN, Dong HL, Xu YP, Zhao LZ, Zhang FC, Li XF, Wu A, Cheng G, Qin CF.

Emerg Microbes Infect. 2018 Oct 17;7(1):169. doi: 10.1038/s41426-018-0170-6.

3.

E90 subunit vaccine protects mice from Zika virus infection and microcephaly.

Zhu X, Li C, Afridi SK, Zu S, Xu JW, Quanquin N, Yang H, Cheng G, Xu Z.

Acta Neuropathol Commun. 2018 Aug 10;6(1):77. doi: 10.1186/s40478-018-0572-7.

4.

PARP12 suppresses Zika virus infection through PARP-dependent degradation of NS1 and NS3 viral proteins.

Li L, Zhao H, Liu P, Li C, Quanquin N, Ji X, Sun N, Du P, Qin CF, Lu N, Cheng G.

Sci Signal. 2018 Jun 19;11(535). pii: eaas9332. doi: 10.1126/scisignal.aas9332.

5.

Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice.

Li C, Zhu X, Ji X, Quanquin N, Deng YQ, Tian M, Aliyari R, Zuo X, Yuan L, Afridi SK, Li XF, Jung JU, Nielsen-Saines K, Qin FX, Qin CF, Xu Z, Cheng G.

EBioMedicine. 2017 Oct;24:189-194. doi: 10.1016/j.ebiom.2017.09.034. Epub 2017 Sep 28.

6.

Generation of a Live Attenuated Influenza Vaccine that Elicits Broad Protection in Mice and Ferrets.

Wang L, Liu SY, Chen HW, Xu J, Chapon M, Zhang T, Zhou F, Wang YE, Quanquin N, Wang G, Tian X, He Z, Liu L, Yu W, Sanchez DJ, Liang Y, Jiang T, Modlin R, Bloom BR, Li Q, Deng JC, Zhou P, Qin FX, Cheng G.

Cell Host Microbe. 2017 Mar 8;21(3):334-343. doi: 10.1016/j.chom.2017.02.007.

7.

Potential for treatment and a Zika virus vaccine.

Quanquin N, Wang L, Cheng G.

Curr Opin Pediatr. 2017 Feb;29(1):114-121. doi: 10.1097/MOP.0000000000000441. Review.

8.

Functional Genomics Reveals Linkers Critical for Influenza Virus Polymerase.

Wang L, Wu A, Wang YE, Quanquin N, Li C, Wang J, Chen HW, Liu S, Liu P, Zhang H, Qin FX, Jiang T, Cheng G.

J Virol. 2015 Dec 30;90(6):2938-47. doi: 10.1128/JVI.02400-15.

9.

Topical resiquimod protects against visceral infection with Leishmania infantum chagasi in mice.

Craft N, Birnbaum R, Quanquin N, Erfe MC, Quant C, Haskell J, Bruhn KW.

Clin Vaccine Immunol. 2014 Sep;21(9):1314-22. doi: 10.1128/CVI.00338-14. Epub 2014 Jul 16.

10.

Genetic alteration of Mycobacterium smegmatis to improve mycobacterium-mediated transfer of plasmid DNA into mammalian cells and DNA immunization.

Mo Y, Quanquin NM, Vecino WH, Ranganathan UD, Tesfa L, Bourn W, Derbyshire KM, Letvin NL, Jacobs WR Jr, Fennelly GJ.

Infect Immun. 2007 Oct;75(10):4804-16. Epub 2007 Jul 30.

11.

Mucosal immunization with attenuated Shigella flexneri harboring an influenza hemagglutinin DNA vaccine protects mice against a lethal influenza challenge.

Vecino WH, Quanquin NM, Martinez-Sobrido L, Fernandez-Sesma A, GarcĂ­a-Sastre A, Jacobs WR Jr, Fennelly GJ.

Virology. 2004 Aug 1;325(2):192-9.

12.

Immunization of mice with a TolA-like surface protein of Trypanosoma cruzi generates CD4(+) T-cell-dependent parasiticidal activity.

Quanquin NM, Galaviz C, Fouts DL, Wrightsman RA, Manning JE.

Infect Immun. 1999 Sep;67(9):4603-12.

Supplemental Content

Loading ...
Support Center